Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid

Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy 1 , 2 , but involv...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) Vol. 565; no. 7741; pp. 654 - 658
Main Authors: Miller, Alexandra M., Shah, Ronak H., Pentsova, Elena I., Pourmaleki, Maryam, Briggs, Samuel, Distefano, Natalie, Zheng, Youyun, Skakodub, Anna, Mehta, Smrutiben A., Campos, Carl, Hsieh, Wan-Ying, Selcuklu, S. Duygu, Ling, Lilan, Meng, Fanli, Jing, Xiaohong, Samoila, Aliaksandra, Bale, Tejus A., Tsui, Dana W. Y., Grommes, Christian, Viale, Agnes, Souweidane, Mark M., Tabar, Viviane, Brennan, Cameron W., Reiner, Anne S., Rosenblum, Marc, Panageas, Katherine S., DeAngelis, Lisa M., Young, Robert J., Berger, Michael F., Mellinghoff, Ingo K.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01.01.2019
Nature Publishing Group
Subjects:
631/1647/2217
631/67/1922
Adults
Analysis
Biopsy
Blood circulation
Brain
Brain cancer
Brain tumors
Cancer therapies
Cerebrospinal fluid
Chemotherapy
Chromosome deletion
Consortia
Deoxyribonucleic acid
Development and progression
Diagnosis
DNA
Evolution
Evolution, Molecular
Gene deletion
Genes, Neoplasm - genetics
Genome, Human - genetics
Genomes
Genomics
Genotypes
Genotyping
Glioblastoma - cerebrospinal fluid
Glioblastoma - genetics
Glioblastoma - pathology
Glioma
Glioma - cerebrospinal fluid
Glioma - genetics
Glioma - pathology
Gliomas
Growth factors
Humanities and Social Sciences
Humans
Isocitrate dehydrogenase
Letter
Liquid Biopsy
Methods
Morbidity
multidisciplinary
Mutation
Neoplasm Grading
Oncology
Patients
Science
Science (multidisciplinary)
Signal transduction
Signs and symptoms
Surgery
Telomerase
Tumorigenesis
Tumors
United States
ISSN:0028-0836, 1476-4687, 1476-4687
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy 1 , 2 , but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease 3 – 10 . While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging 11 , 12 , sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost 13 , 14 . We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 ( IDH1 ) or IDH2 1 , 2 , were shared in all matched ctDNA-positive CSF–tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers. Identification and sequencing of circulating tumour DNA in the cerebrospinal fluid of patients with glioma.
AbstractList Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy.sup.1,2, but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease.sup.3-10. While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging.sup.11,12, sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost.sup.13,14. We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 (IDH1) or IDH2.sup.1,2, were shared in all matched ctDNA-positive CSF-tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers.
Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy , but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease . While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging , sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost . We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 (IDH1) or IDH2 , were shared in all matched ctDNA-positive CSF-tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers.
Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy, but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease. While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging, sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost. We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 (IDH1) or IDH2, were shared in all matched ctDNA-positive CSF-tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers.
Diffuse gliomas comprise the most common malignant brain tumors in adults and include glioblastomas (GBM) and World Health Organization (WHO) grade II and grade III tumors, sometimes referred to as lower-grade gliomas (LGGs). Genetic tumor profiling is used for disease classification and to guide therapy1,2, but involves brain surgery for tissue collection and repeated tumor biopsies may be necessary for accurate genotyping over the course of the disease 3–10. While detection of circulating tumor DNA (ctDNA) in blood remains challenging for patients with primary brain tumors 11,12, sequencing of cerebrospinal fluid (CSF) ctDNA may provide an alternative to genotype glioma at lower morbidity and cost 13,14. We therefore evaluated the representation of the glioma genome in CSF from 85 glioma patients who underwent a lumbar puncture for evaluation of neurological signs or symptoms. Tumor-derived DNA was detected in CSF from 42/85 (49.4 %) patients and was associated with disease burden and adverse outcome. The genomic landscape of glioma in CSF contained a broad spectrum of genetic alterations and closely resembled the genome in tumor biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 (IDH1) or IDH2 1,2, were shared in all matched ctDNA-positive CSF/tumor pairs, whereas we observed considerable evolution in growth factor receptor signaling pathways. The ability to monitor evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers.
Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy.sup.1,2, but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease.sup.3-10. While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging.sup.11,12, sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost.sup.13,14. We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 (IDH1) or IDH2.sup.1,2, were shared in all matched ctDNA-positive CSF-tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers. Identification and sequencing of circulating tumour DNA in the cerebrospinal fluid of patients with glioma.
Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy1,2, but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease3-10. While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging11,12, sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost13,14. We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 (IDH1) or IDH21,2, were shared in all matched ctDNA-positive CSF-tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers.Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy1,2, but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease3-10. While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging11,12, sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost13,14. We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 (IDH1) or IDH21,2, were shared in all matched ctDNA-positive CSF-tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers.
Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy 1 , 2 , but involves brain surgery for tissue collection; repeated tumour biopsies may be necessary for accurate genotyping over the course of the disease 3 – 10 . While the detection of circulating tumour DNA (ctDNA) in the blood of patients with primary brain tumours remains challenging 11 , 12 , sequencing of ctDNA from the cerebrospinal fluid (CSF) may provide an alternative way to genotype gliomas with lower morbidity and cost 13 , 14 . We therefore evaluated the representation of the glioma genome in CSF from 85 patients with gliomas who underwent a lumbar puncture because they showed neurological signs or symptoms. Here we show that tumour-derived DNA was detected in CSF from 42 out of 85 patients (49.4%) and was associated with disease burden and adverse outcome. The genomic landscape of glioma in the CSF included a broad spectrum of genetic alterations and closely resembled the genomes of tumour biopsies. Alterations that occur early during tumorigenesis, such as co-deletion of chromosome arms 1p and 19q (1p/19q codeletion) and mutations in the metabolic genes isocitrate dehydrogenase 1 ( IDH1 ) or IDH2 1 , 2 , were shared in all matched ctDNA-positive CSF–tumour pairs, whereas growth factor receptor signalling pathways showed considerable evolution. The ability to monitor the evolution of the glioma genome through a minimally invasive technique could advance the clinical development and use of genotype-directed therapies for glioma, one of the most aggressive human cancers. Identification and sequencing of circulating tumour DNA in the cerebrospinal fluid of patients with glioma.
Audience Academic
Author Ling, Lilan
Jing, Xiaohong
Grommes, Christian
Selcuklu, S. Duygu
Reiner, Anne S.
Rosenblum, Marc
Young, Robert J.
Pourmaleki, Maryam
Zheng, Youyun
Skakodub, Anna
Meng, Fanli
Campos, Carl
Brennan, Cameron W.
Hsieh, Wan-Ying
Tsui, Dana W. Y.
Tabar, Viviane
Shah, Ronak H.
Panageas, Katherine S.
DeAngelis, Lisa M.
Mellinghoff, Ingo K.
Pentsova, Elena I.
Bale, Tejus A.
Viale, Agnes
Souweidane, Mark M.
Briggs, Samuel
Miller, Alexandra M.
Mehta, Smrutiben A.
Berger, Michael F.
Distefano, Natalie
Samoila, Aliaksandra
AuthorAffiliation 4 Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
7 Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
5 Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
1 Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
10 Department of Pharmacology, Weill-Cornell School of Medicine, New York, NY 10021, USA
3 Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
8 Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
2 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
6 Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
9 Department of Neurological Surgery, Weill-Cornell School of Medicine, New York, NY 10021, USA
AuthorAffiliation_xml – name: 2 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
– name: 6 Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
– name: 10 Department of Pharmacology, Weill-Cornell School of Medicine, New York, NY 10021, USA
– name: 8 Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
– name: 1 Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
– name: 9 Department of Neurological Surgery, Weill-Cornell School of Medicine, New York, NY 10021, USA
– name: 3 Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
– name: 4 Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
– name: 7 Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
– name: 5 Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
Author_xml – sequence: 1
  givenname: Alexandra M.
  surname: Miller
  fullname: Miller, Alexandra M.
  organization: Department of Neurology, Memorial Sloan Kettering Cancer Center
– sequence: 2
  givenname: Ronak H.
  surname: Shah
  fullname: Shah, Ronak H.
  organization: Department of Pathology, Memorial Sloan Kettering Cancer Center, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, Medical Genetics and Human Genomics, Department of Pediatrics, Northwell Health
– sequence: 3
  givenname: Elena I.
  surname: Pentsova
  fullname: Pentsova, Elena I.
  organization: Department of Neurology, Memorial Sloan Kettering Cancer Center
– sequence: 4
  givenname: Maryam
  surname: Pourmaleki
  fullname: Pourmaleki, Maryam
  organization: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
– sequence: 5
  givenname: Samuel
  surname: Briggs
  fullname: Briggs, Samuel
  organization: Department of Neurology, Memorial Sloan Kettering Cancer Center
– sequence: 6
  givenname: Natalie
  surname: Distefano
  fullname: Distefano, Natalie
  organization: Department of Neurosurgery, Memorial Sloan Kettering Cancer Center
– sequence: 7
  givenname: Youyun
  surname: Zheng
  fullname: Zheng, Youyun
  organization: Department of Pathology, Memorial Sloan Kettering Cancer Center, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
– sequence: 8
  givenname: Anna
  surname: Skakodub
  fullname: Skakodub, Anna
  organization: Department of Neurology, Memorial Sloan Kettering Cancer Center
– sequence: 9
  givenname: Smrutiben A.
  surname: Mehta
  fullname: Mehta, Smrutiben A.
  organization: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
– sequence: 10
  givenname: Carl
  surname: Campos
  fullname: Campos, Carl
  organization: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
– sequence: 11
  givenname: Wan-Ying
  surname: Hsieh
  fullname: Hsieh, Wan-Ying
  organization: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
– sequence: 12
  givenname: S. Duygu
  surname: Selcuklu
  fullname: Selcuklu, S. Duygu
  organization: Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
– sequence: 13
  givenname: Lilan
  surname: Ling
  fullname: Ling, Lilan
  organization: Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
– sequence: 14
  givenname: Fanli
  surname: Meng
  fullname: Meng, Fanli
  organization: Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
– sequence: 15
  givenname: Xiaohong
  surname: Jing
  fullname: Jing, Xiaohong
  organization: Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
– sequence: 16
  givenname: Aliaksandra
  surname: Samoila
  fullname: Samoila, Aliaksandra
  organization: Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center
– sequence: 17
  givenname: Tejus A.
  surname: Bale
  fullname: Bale, Tejus A.
  organization: Department of Pathology, Memorial Sloan Kettering Cancer Center
– sequence: 18
  givenname: Dana W. Y.
  surname: Tsui
  fullname: Tsui, Dana W. Y.
  organization: Department of Pathology, Memorial Sloan Kettering Cancer Center, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
– sequence: 19
  givenname: Christian
  surname: Grommes
  fullname: Grommes, Christian
  organization: Department of Neurology, Memorial Sloan Kettering Cancer Center
– sequence: 20
  givenname: Agnes
  surname: Viale
  fullname: Viale, Agnes
  organization: Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
– sequence: 21
  givenname: Mark M.
  surname: Souweidane
  fullname: Souweidane, Mark M.
  organization: Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, Department of Neurological Surgery, Weill Cornell Medical College
– sequence: 22
  givenname: Viviane
  surname: Tabar
  fullname: Tabar, Viviane
  organization: Department of Neurosurgery, Memorial Sloan Kettering Cancer Center
– sequence: 23
  givenname: Cameron W.
  surname: Brennan
  fullname: Brennan, Cameron W.
  organization: Department of Neurosurgery, Memorial Sloan Kettering Cancer Center
– sequence: 24
  givenname: Anne S.
  surname: Reiner
  fullname: Reiner, Anne S.
  organization: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center
– sequence: 25
  givenname: Marc
  surname: Rosenblum
  fullname: Rosenblum, Marc
  organization: Department of Pathology, Memorial Sloan Kettering Cancer Center
– sequence: 26
  givenname: Katherine S.
  surname: Panageas
  fullname: Panageas, Katherine S.
  organization: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center
– sequence: 27
  givenname: Lisa M.
  surname: DeAngelis
  fullname: DeAngelis, Lisa M.
  organization: Department of Neurology, Memorial Sloan Kettering Cancer Center
– sequence: 28
  givenname: Robert J.
  surname: Young
  fullname: Young, Robert J.
  organization: Department of Radiology, Memorial Sloan Kettering Cancer Center
– sequence: 29
  givenname: Michael F.
  surname: Berger
  fullname: Berger, Michael F.
  email: bergerm1@mskcc.org
  organization: Department of Pathology, Memorial Sloan Kettering Cancer Center, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College
– sequence: 30
  givenname: Ingo K.
  surname: Mellinghoff
  fullname: Mellinghoff, Ingo K.
  email: mellingi@mskcc.org
  organization: Department of Neurology, Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, Department of Pharmacology, Weill Cornell Medical College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30675060$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhi1URLeFH8AFRXCBQ4qdD9u5IFUVH5UqIZVythxnknVx7F07qeDfM8u2tFstyIdInud9PZl5j8iBDx4IecnoCaOlfJ8qVkueU9bkVMoiL5-QBasEzysuxQFZUFpIrJT8kByldE0prZmonpHDknJRU04X5PIqavPD-iGb5jHMMYOb4ObJBp9Znw3OhlFn0zKGeVhmzq5n22WtDatkIWWhzwxEaGNIK-u1y3qH9efkaa9dghe332Py_dPHq7Mv-cXXz-dnpxe5qZtywh7Lpqs4500nWsF0AcD6RhcdNU1fyF5TI3XVgtYtcA2GU91xXjPDO8NNIctj8mHru5rbEToDforaqVW0o46_VNBW7Va8Xaoh3Che1aKhAg3e3hrEsJ4hTWq0yYBz2kOYkyqYaKqqrosG0TeP0GscFv7yH0rWrJG1uKcG7UBZ3wd812xM1SmWC4H7Ykjle6gBPGCTuODe4vUO_3oPb1Z2rR5CJ3sgPB2M1ux1fbcjQGaCn9Og55TU-bfLXfbVw0n_HfFdjBAQW8BgFFKEXhk76U2KsAvrFKNqE1i1DazCwKpNYFWJSvZIeWf-P02x1SRk_QDxfhn_Fv0GU7767g
CitedBy_id crossref_primary_10_1016_j_cyto_2023_156344
crossref_primary_10_1097_WCO_0000000000000869
crossref_primary_10_1016_j_tips_2019_12_003
crossref_primary_10_2174_1381612826666200603132456
crossref_primary_10_1016_j_acra_2024_03_019
crossref_primary_10_1080_14789450_2025_2514841
crossref_primary_10_1155_2022_4476412
crossref_primary_10_1093_neuonc_noae277
crossref_primary_10_1093_neuonc_noae276
crossref_primary_10_1186_s40644_023_00638_8
crossref_primary_10_1016_j_mcp_2019_101480
crossref_primary_10_1002_ctm2_567
crossref_primary_10_3389_fcell_2020_00045
crossref_primary_10_1371_journal_pone_0266623
crossref_primary_10_3390_cancers13112652
crossref_primary_10_3390_ijms22126533
crossref_primary_10_1038_s41419_022_04872_z
crossref_primary_10_1158_1078_0432_CCR_19_3467
crossref_primary_10_3389_fneur_2020_544680
crossref_primary_10_1016_j_ccell_2019_12_004
crossref_primary_10_1016_j_bios_2024_116356
crossref_primary_10_3390_cancers13215429
crossref_primary_10_1007_s10143_025_03593_z
crossref_primary_10_3390_biomedicines12020375
crossref_primary_10_1093_neuonc_noaf140
crossref_primary_10_3390_ijms25147974
crossref_primary_10_3389_fonc_2022_1030366
crossref_primary_10_1016_j_tranon_2023_101688
crossref_primary_10_1186_s12935_021_01818_x
crossref_primary_10_3389_fonc_2020_615400
crossref_primary_10_1007_s12017_021_08677_9
crossref_primary_10_15252_emmm_202012881
crossref_primary_10_1016_j_bbe_2024_07_002
crossref_primary_10_3390_cancers11081197
crossref_primary_10_1016_j_jlb_2025_100293
crossref_primary_10_1093_neuonc_noad075
crossref_primary_10_1007_s00431_019_03545_y
crossref_primary_10_3389_fonc_2019_00506
crossref_primary_10_3389_fonc_2023_1238607
crossref_primary_10_1007_s11060_021_03861_0
crossref_primary_10_3390_ijms23169006
crossref_primary_10_1186_s13073_019_0632_z
crossref_primary_10_3389_fphar_2024_1442700
crossref_primary_10_3390_ijms20153825
crossref_primary_10_1186_s40478_024_01879_9
crossref_primary_10_1016_j_critrevonc_2020_102879
crossref_primary_10_1016_j_ccell_2021_09_012
crossref_primary_10_1016_j_prp_2024_155571
crossref_primary_10_3390_cancers14122891
crossref_primary_10_1016_j_jneuroim_2025_578570
crossref_primary_10_3389_fonc_2021_662260
crossref_primary_10_1007_s11864_019_0689_3
crossref_primary_10_1097_CM9_0000000000000843
crossref_primary_10_1227_neu_0000000000003384
crossref_primary_10_3390_life14101312
crossref_primary_10_3389_fonc_2021_714428
crossref_primary_10_7759_cureus_41221
crossref_primary_10_1002_smtd_202200547
crossref_primary_10_1007_s11060_020_03566_w
crossref_primary_10_1016_j_clineuro_2025_108821
crossref_primary_10_1038_s41598_021_85178_6
crossref_primary_10_3389_fimmu_2025_1512867
crossref_primary_10_1093_clinchem_hvae178
crossref_primary_10_1002_mco2_564
crossref_primary_10_1093_neuros_nyz177
crossref_primary_10_1158_1078_0432_CCR_24_3910
crossref_primary_10_3389_fonc_2021_625838
crossref_primary_10_23736_S0390_5616_20_05112_7
crossref_primary_10_3390_cancers12071831
crossref_primary_10_3390_ijms21134760
crossref_primary_10_1007_s11060_022_04060_1
crossref_primary_10_1038_s41571_019_0178_4
crossref_primary_10_1007_s00701_021_05014_8
crossref_primary_10_1007_s10555_020_09850_5
crossref_primary_10_1016_j_ijrobp_2019_10_017
crossref_primary_10_1371_journal_pone_0223558
crossref_primary_10_1182_blood_2020010137
crossref_primary_10_3390_cancers14246025
crossref_primary_10_3390_cancers16010219
crossref_primary_10_1007_s11426_023_1727_9
crossref_primary_10_1038_s41417_024_00740_4
crossref_primary_10_1016_j_tranon_2024_101881
crossref_primary_10_3390_brainsci14040331
crossref_primary_10_1007_s11426_020_9743_2
crossref_primary_10_1097_PPO_0000000000000759
crossref_primary_10_1227_neu_0000000000001982
crossref_primary_10_3389_fonc_2024_1409383
crossref_primary_10_1093_neuonc_noad181
crossref_primary_10_1038_s41571_021_00489_x
crossref_primary_10_1007_s11912_020_0877_0
crossref_primary_10_1155_2022_4938587
crossref_primary_10_3389_fmolb_2023_1216102
crossref_primary_10_1007_s00401_025_02880_9
crossref_primary_10_3390_cancers13051045
crossref_primary_10_1016_j_cellsig_2021_110062
crossref_primary_10_3390_biomedicines13081963
crossref_primary_10_3390_cancers16051009
crossref_primary_10_1002_advs_202412680
crossref_primary_10_1093_neuonc_noaa106
crossref_primary_10_1186_s13046_022_02334_0
crossref_primary_10_1038_s41698_024_00541_w
crossref_primary_10_1016_j_jns_2023_120762
crossref_primary_10_1016_j_yamp_2019_07_011
crossref_primary_10_1158_1078_0432_CCR_22_2903
crossref_primary_10_1038_s41698_022_00261_z
crossref_primary_10_3389_fonc_2021_584988
crossref_primary_10_3389_fonc_2022_934159
crossref_primary_10_3390_cancers11070950
crossref_primary_10_1038_s41698_025_00876_y
crossref_primary_10_3389_fcell_2021_754873
crossref_primary_10_3389_fimmu_2022_958360
crossref_primary_10_3389_fonc_2022_893769
crossref_primary_10_1007_s40291_024_00754_6
crossref_primary_10_1080_01616412_2024_2395069
crossref_primary_10_1016_j_bbrc_2020_02_017
crossref_primary_10_1001_jamanetworkopen_2021_20040
crossref_primary_10_1007_s11060_023_04555_5
crossref_primary_10_1186_s40478_025_01960_x
crossref_primary_10_1007_s11060_023_04484_3
crossref_primary_10_1038_s41587_021_00857_z
crossref_primary_10_1200_EDBK_280967
crossref_primary_10_3390_cancers15215198
crossref_primary_10_3389_fonc_2021_742037
crossref_primary_10_3389_pore_2023_1611391
crossref_primary_10_1016_j_jmoldx_2021_03_001
crossref_primary_10_1038_s41698_025_00909_6
crossref_primary_10_1016_j_path_2020_02_003
crossref_primary_10_3389_fimmu_2022_882452
crossref_primary_10_1158_1078_0432_CCR_24_1563
crossref_primary_10_3390_molecules27217198
crossref_primary_10_3389_fonc_2024_1395985
crossref_primary_10_1016_j_ibneur_2025_04_007
crossref_primary_10_1038_s41571_022_00660_y
crossref_primary_10_1148_radiol_243521
crossref_primary_10_1016_j_omtn_2023_03_015
crossref_primary_10_1016_j_wneu_2024_06_142
crossref_primary_10_1097_CCO_0000000000001079
crossref_primary_10_1097_CM9_0000000000002446
crossref_primary_10_1002_pbc_31288
crossref_primary_10_1007_s12031_025_02361_4
crossref_primary_10_1016_j_ccr_2023_215070
crossref_primary_10_1038_s41416_021_01594_5
crossref_primary_10_1080_15257770_2025_2551841
crossref_primary_10_1093_clinchem_hvae140
crossref_primary_10_3389_fonc_2022_891917
crossref_primary_10_1007_s40291_021_00513_x
crossref_primary_10_1093_neuonc_noab012
crossref_primary_10_1016_j_cca_2024_117878
crossref_primary_10_3389_fonc_2022_798018
crossref_primary_10_1093_oncolo_oyac280
crossref_primary_10_1093_neuonc_noz156
crossref_primary_10_3171_2019_9_FOCUS19699
crossref_primary_10_1016_j_wneu_2024_06_146
crossref_primary_10_1038_s41568_022_00486_x
crossref_primary_10_1200_EDBK_280955
crossref_primary_10_1063_5_0135525
crossref_primary_10_3390_cancers17162700
crossref_primary_10_1007_s00415_020_09884_3
crossref_primary_10_1016_j_bbcan_2025_189367
crossref_primary_10_1016_j_yao_2022_01_006
crossref_primary_10_3389_fonc_2024_1513073
crossref_primary_10_25259_SNI_52_2023
crossref_primary_10_1155_2020_7035847
crossref_primary_10_1016_j_jconrel_2019_08_010
crossref_primary_10_1111_jnc_15350
crossref_primary_10_1016_j_heliyon_2023_e14339
crossref_primary_10_1007_s00432_021_03536_3
crossref_primary_10_1038_s41576_021_00338_8
crossref_primary_10_1136_jitc_2022_006284
crossref_primary_10_1016_j_yamp_2022_08_002
crossref_primary_10_3390_ijms24119723
crossref_primary_10_1158_2159_8290_CD_25_0074
crossref_primary_10_3390_cancers13091989
crossref_primary_10_3171_2019_5_PEDS18376
crossref_primary_10_1016_j_bios_2025_117202
crossref_primary_10_3389_fgene_2021_799799
crossref_primary_10_3390_cells11121901
crossref_primary_10_2147_CMAR_S269572
crossref_primary_10_3389_fsurg_2022_874143
crossref_primary_10_1186_s12916_024_03775_4
crossref_primary_10_3171_2019_6_PEDS19259
crossref_primary_10_1093_neuros_nyaa025
crossref_primary_10_1002_anbr_202100008
crossref_primary_10_3389_pore_2022_1610024
crossref_primary_10_2217_cns_2019_0010
crossref_primary_10_1186_s12885_025_14711_x
crossref_primary_10_1007_s11912_023_01440_2
crossref_primary_10_1007_s11912_024_01517_6
crossref_primary_10_1016_j_neurol_2022_02_462
crossref_primary_10_3390_cancers13040758
crossref_primary_10_1016_j_tranon_2022_101451
crossref_primary_10_1002_onco_13858
crossref_primary_10_3390_diagnostics12040870
crossref_primary_10_1177_17588359221100863
crossref_primary_10_1227_neu_0000000000003679
crossref_primary_10_3389_fonc_2021_665235
crossref_primary_10_3389_fphys_2023_1219291
crossref_primary_10_3390_biom15050658
crossref_primary_10_3390_ijms23137474
crossref_primary_10_3389_fonc_2022_836891
crossref_primary_10_1016_j_wneu_2022_06_070
crossref_primary_10_1093_neuonc_noad100
crossref_primary_10_1212_CON_0000000000001352
crossref_primary_10_1093_neuonc_noab282
crossref_primary_10_1002_biof_2061
crossref_primary_10_3389_fonc_2022_664420
crossref_primary_10_1080_14737159_2021_1910025
crossref_primary_10_1186_s12987_020_00181_9
crossref_primary_10_1016_j_mric_2024_04_006
crossref_primary_10_1093_neuonc_noad229
crossref_primary_10_3389_fneur_2022_865171
crossref_primary_10_1002_adbi_202000029
crossref_primary_10_1097_WCO_0000000000001317
crossref_primary_10_3390_diagnostics13182888
crossref_primary_10_1016_j_xcrm_2025_102320
crossref_primary_10_1038_s41598_023_34902_5
crossref_primary_10_1186_s40478_024_01887_9
crossref_primary_10_1038_s41416_023_02446_0
crossref_primary_10_1158_1078_0432_CCR_19_2533
crossref_primary_10_1186_s12916_022_02595_8
crossref_primary_10_1158_1078_0432_CCR_19_4159
crossref_primary_10_3389_fmolb_2022_885597
crossref_primary_10_1016_j_annonc_2021_10_215
crossref_primary_10_1097_MD_0000000000021196
crossref_primary_10_1158_1078_0432_CCR_22_2434
crossref_primary_10_1212_WNL_0000000000012833
crossref_primary_10_2174_1381612826666200302105715
crossref_primary_10_1093_neuonc_noac264
crossref_primary_10_1177_19418744221106003
crossref_primary_10_1016_j_canlet_2025_217471
crossref_primary_10_1093_neuonc_noab299
crossref_primary_10_1093_neuonc_noae203
crossref_primary_10_1155_2022_1952891
crossref_primary_10_1038_s43018_023_00585_0
crossref_primary_10_1111_nan_12553
crossref_primary_10_1038_s41390_025_04320_6
crossref_primary_10_1371_journal_pone_0234182
crossref_primary_10_1227_neu_0000000000003659
crossref_primary_10_3390_diagnostics11040681
crossref_primary_10_1200_PO_25_00360
crossref_primary_10_1007_s11060_021_03837_0
crossref_primary_10_1186_s12885_023_11726_0
crossref_primary_10_1007_s00432_022_04011_3
crossref_primary_10_1002_adhm_202400438
crossref_primary_10_1038_s41467_020_19175_0
crossref_primary_10_1016_j_bbcan_2024_189243
crossref_primary_10_1093_neuonc_noab146
crossref_primary_10_1016_j_cellsig_2024_111380
crossref_primary_10_1093_neuonc_noab023
crossref_primary_10_1016_j_jocn_2019_08_044
crossref_primary_10_1007_s11060_020_03682_7
crossref_primary_10_1093_neuonc_noab026
crossref_primary_10_1038_s41597_025_05550_3
crossref_primary_10_1007_s11060_022_03949_1
crossref_primary_10_1080_10428194_2019_1639169
crossref_primary_10_1093_nop_npaa083
crossref_primary_10_3171_2019_5_JNS19364
crossref_primary_10_3390_ijms23094879
crossref_primary_10_1158_1078_0432_CCR_20_2066
crossref_primary_10_1016_j_ctarc_2023_100709
crossref_primary_10_2147_OTT_S237841
crossref_primary_10_1007_s10014_023_00452_x
crossref_primary_10_1177_20552076241271769
crossref_primary_10_1186_s40478_024_01780_5
crossref_primary_10_3390_ijms25168830
crossref_primary_10_1007_s00018_020_03529_4
crossref_primary_10_1080_14737140_2020_1735367
crossref_primary_10_1093_neuonc_noac004
crossref_primary_10_1016_j_annonc_2025_02_005
crossref_primary_10_2217_cns_2021_0008
crossref_primary_10_1111_nan_12691
crossref_primary_10_3390_ijms21020685
crossref_primary_10_1016_j_jlb_2025_100317
crossref_primary_10_1093_clinchem_hvad115
crossref_primary_10_1016_j_annonc_2022_09_150
crossref_primary_10_1007_s10014_021_00403_4
crossref_primary_10_1038_s41374_021_00719_x
crossref_primary_10_1038_s41698_024_00582_1
crossref_primary_10_1016_j_cyto_2024_156663
crossref_primary_10_1111_pcmr_12861
crossref_primary_10_3390_ijms25094882
crossref_primary_10_1016_j_ccell_2020_03_007
crossref_primary_10_1038_s41467_025_61163_9
crossref_primary_10_1093_neuros_nyab063
crossref_primary_10_1001_jamanetworkopen_2020_9077
crossref_primary_10_1007_s10014_025_00517_z
crossref_primary_10_7759_cureus_51712
crossref_primary_10_1016_j_jlb_2024_100142
crossref_primary_10_1186_s40364_023_00476_7
crossref_primary_10_1371_journal_pcbi_1008266
crossref_primary_10_1093_brain_awac438
crossref_primary_10_1016_j_jlb_2024_100146
crossref_primary_10_1186_s13046_025_03371_1
crossref_primary_10_1002_tcr_202000080
crossref_primary_10_1038_s41388_019_1127_5
crossref_primary_10_3322_caac_21650
crossref_primary_10_1016_j_humgen_2024_201333
crossref_primary_10_1016_j_jmoldx_2020_10_013
crossref_primary_10_1038_s41416_019_0603_6
crossref_primary_10_1038_s41591_025_03538_5
crossref_primary_10_3390_cancers16091681
crossref_primary_10_1146_annurev_bioeng_110222_111259
crossref_primary_10_3390_cancers15112879
crossref_primary_10_3390_cancers13061294
crossref_primary_10_1016_j_critrevonc_2025_104650
crossref_primary_10_1007_s00262_024_03774_7
crossref_primary_10_1097_PPO_0000000000000541
crossref_primary_10_1200_PO_24_00921
crossref_primary_10_3389_fgene_2023_1152470
crossref_primary_10_1002_ana_26080
crossref_primary_10_1093_neuonc_noad032
crossref_primary_10_1007_s11912_019_0818_y
crossref_primary_10_14791_btrt_2025_0018
crossref_primary_10_3389_fonc_2023_1222797
crossref_primary_10_1016_j_canlet_2020_03_021
crossref_primary_10_1016_j_jhep_2024_10_020
crossref_primary_10_3390_ijms26030917
crossref_primary_10_1002_adfm_202307816
crossref_primary_10_3390_cells14110848
crossref_primary_10_1016_j_omton_2025_200994
crossref_primary_10_1111_cas_15084
crossref_primary_10_1038_s41392_025_02299_4
crossref_primary_10_3390_metabo10120478
crossref_primary_10_1038_s41375_024_02279_7
crossref_primary_10_3390_biomedicines10030728
crossref_primary_10_1093_brain_awad195
crossref_primary_10_1016_j_hoc_2021_08_008
crossref_primary_10_1016_j_intimp_2022_109173
crossref_primary_10_1038_s41416_025_03047_9
crossref_primary_10_1158_2159_8290_CD_24_0134
crossref_primary_10_3390_cancers14143394
crossref_primary_10_1016_j_ejpb_2019_02_014
crossref_primary_10_1038_s41598_020_71161_0
crossref_primary_10_1093_neuonc_noac030
crossref_primary_10_1093_neuonc_noac035
crossref_primary_10_1007_s00432_024_05997_8
crossref_primary_10_1038_s41598_019_56473_0
crossref_primary_10_1158_1078_0432_CCR_20_3083
crossref_primary_10_1158_1078_0432_CCR_24_1814
crossref_primary_10_1136_bmjno_2020_000069
crossref_primary_10_1186_s40478_024_01846_4
crossref_primary_10_3390_cancers16223746
crossref_primary_10_1093_jjco_hyz073
crossref_primary_10_1182_blood_2024023832
crossref_primary_10_3389_fonc_2022_889591
crossref_primary_10_3389_fonc_2021_738651
crossref_primary_10_1002_ijc_34401
crossref_primary_10_1002_pbc_31535
crossref_primary_10_1177_15330338241262483
crossref_primary_10_1093_jnci_djae179
crossref_primary_10_1007_s11912_021_01162_3
crossref_primary_10_1186_s12883_024_03655_7
crossref_primary_10_1016_j_nbd_2020_105021
crossref_primary_10_3390_molecules25030490
crossref_primary_10_1093_neuonc_noab081
crossref_primary_10_1093_neuros_nyaa540
crossref_primary_10_1146_annurev_pathmechdis_012419_032604
crossref_primary_10_1126_scitranslmed_adr4058
crossref_primary_10_1158_1078_0432_CCR_19_3924
crossref_primary_10_3390_cells13030218
crossref_primary_10_1002_ccr3_4551
crossref_primary_10_1016_j_ejca_2021_09_022
crossref_primary_10_1200_EDBK_389322
crossref_primary_10_1634_theoncologist_2020_0258
crossref_primary_10_1200_PO_25_00456
Cites_doi 10.1101/gr.180612.114
10.1016/j.ccell.2015.07.013
10.1038/ng.3273
10.1038/ng.3590
10.1126/science.1239947
10.1200/JCO.2017.76.8671
10.1038/nature07385
10.1093/nar/gkw520
10.1186/s40478-017-0422-z
10.1158/0008-5472.CAN-06-0127
10.1126/science.1164382
10.1016/S0027-5107(00)00020-8
10.1038/ng.3806
10.1016/j.cell.2013.09.034
10.1038/nm.4333
10.1093/bib/bbs017
10.1038/nature11632
10.1200/JCO.2016.66.6487
10.1038/nature12477
10.1158/2159-8290.CD-17-0151
10.1056/NEJMoa1402121
10.1056/NEJMoa1407279
10.1007/s00401-016-1545-1
10.1038/ng.3457
10.1126/scitranslmed.3007094
10.1200/JCO.2017.72.7511
10.1073/pnas.1511694112
ContentType Journal Article
Copyright Springer Nature Limited 2019
COPYRIGHT 2019 Nature Publishing Group
Copyright Nature Publishing Group Jan 31, 2019
Copyright_xml – notice: Springer Nature Limited 2019
– notice: COPYRIGHT 2019 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jan 31, 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QL
7QP
7QR
7RV
7SN
7SS
7ST
7T5
7TG
7TK
7TM
7TO
7U9
7X2
7X7
7XB
88A
88E
88G
88I
8AF
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
8G5
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BEC
BENPR
BGLVJ
BHPHI
BKSAR
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M2M
M2O
M2P
M7N
M7P
M7S
MBDVC
NAPCQ
P5Z
P62
P64
PATMY
PCBAR
PDBOC
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PSYQQ
PTHSS
PYCSY
Q9U
R05
RC3
S0X
SOI
7X8
5PM
DOI 10.1038/s41586-019-0882-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
ProQuest STEM Database
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Computer Science Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
eLibrary
ProQuest Central
ProQuest Technology Collection
Natural Science Collection
Earth, Atmospheric & Aquatic Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database ProQuest
Psychology Database
Research Library
Science Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Research Library (Corporate)
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Earth, Atmospheric & Aquatic Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest One Psychology
Engineering Collection
Environmental Science Collection
ProQuest Central Basic
University of Michigan
Genetics Abstracts
SIRS Editorial
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
elibrary
ProQuest AP Science
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Earth, Atmospheric & Aquatic Science Database
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
University of Michigan
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
SIRS Editorial
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Earth, Atmospheric & Aquatic Science Collection
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Research Library
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest Psychology Journals (Alumni)
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
ProQuest Psychology Journals
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

Agricultural Science Database




MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PATMY
  name: Environmental Science Database
  url: http://search.proquest.com/environmentalscience
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Physics
EISSN 1476-4687
EndPage 658
ExternalDocumentID PMC6457907
A573274151
30675060
10_1038_s41586_019_0882_3
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P50 CA092629
– fundername: NCI NIH HHS
  grantid: P30 CA008748
– fundername: NINDS NIH HHS
  grantid: R35 NS105109
– fundername: NIH HHS
  grantid: 1 R35 NS105109 01
GroupedDBID ---
--Z
-DZ
-ET
-~X
.55
.CO
.XZ
07C
0R~
0WA
123
186
1OL
1VR
29M
2KS
2XV
39C
41X
53G
5RE
6TJ
70F
7RV
7X2
7X7
7XC
85S
88A
88E
88I
8AF
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
8G5
8R4
8R5
8WZ
97F
97L
A6W
A7Z
AAEEF
AAHBH
AAHTB
AAIKC
AAKAB
AAMNW
AASDW
AAYEP
AAYZH
AAZLF
ABDQB
ABFSI
ABIVO
ABJCF
ABJNI
ABLJU
ABOCM
ABPEJ
ABPPZ
ABUWG
ABWJO
ABZEH
ACBEA
ACBWK
ACGFO
ACGFS
ACGOD
ACIWK
ACKOT
ACMJI
ACNCT
ACPRK
ACWUS
ADBBV
ADFRT
ADUKH
AENEX
AEUYN
AFBBN
AFFNX
AFKRA
AFLOW
AFRAH
AFSHS
AGAYW
AGHSJ
AGHTU
AGSOS
AHMBA
AHSBF
AIDAL
AIDUJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
ARAPS
ARMCB
ASPBG
ATCPS
ATWCN
AVWKF
AXYYD
AZFZN
AZQEC
BBNVY
BCU
BEC
BENPR
BGLVJ
BHPHI
BIN
BKEYQ
BKKNO
BKSAR
BPHCQ
BVXVI
CCPQU
CJ0
CS3
D1I
D1J
D1K
DU5
DWQXO
E.-
E.L
EAP
EBS
EE.
EJD
EMH
EPS
ESX
EX3
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HG6
HMCUK
HVGLF
HZ~
I-F
IAO
ICQ
IEA
IEP
IGS
IH2
IHR
INH
INR
IOF
IPY
ISR
ITC
K6-
KB.
KOO
L6V
L7B
LK5
LK8
LSO
M0K
M0L
M1P
M2M
M2O
M2P
M7P
M7R
M7S
N9A
NAPCQ
NEPJS
O9-
OBC
OES
OHH
OMK
OVD
P2P
P62
PATMY
PCBAR
PDBOC
PKN
PQQKQ
PROAC
PSQYO
PSYQQ
PTHSS
PYCSY
Q2X
R05
RND
RNS
RNT
RNTTT
RXW
S0X
SC5
SHXYY
SIXXV
SJFOW
SJN
SNYQT
SOJ
SV3
TAE
TAOOD
TBHMF
TDRGL
TEORI
TN5
TSG
TWZ
U5U
UIG
UKHRP
UKR
UMD
UQL
VQA
VVN
WH7
WOW
X7M
XIH
XKW
XZL
Y6R
YAE
YCJ
YFH
YIF
YIN
YNT
YOC
YQT
YR2
YR5
YXB
YZZ
Z5M
ZCA
ZE2
~02
~7V
~88
~KM
AARCD
AAYXX
ABFSG
ABUFD
ACSTC
ADXHL
AEZWR
AFANA
AFFHD
AFHIU
AGSTI
AHWEU
AIXLP
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
TUS
.-4
.GJ
.HR
00M
08P
0B8
1CY
1VW
354
3EH
3O-
3V.
4.4
41~
42X
4R4
663
79B
9M8
A8Z
AAJYS
AAKAS
AAVBQ
AAYOK
ABAWZ
ABDBF
ABDPE
ABEFU
ABMOR
ABNNU
ABTAH
ACBNA
ACBTR
ACRPL
ACTDY
ACUHS
ADNMO
ADRHT
ADYSU
ADZCM
AFFDN
AFHKK
AGCDD
AGGDT
AGNAY
AGOIJ
AIYXT
AJUXI
APEBS
ARTTT
B0M
BCR
BDKGC
BES
BKOMP
BLC
CGR
CUY
CVF
DB5
DO4
EAD
EAS
EAZ
EBC
EBD
EBO
ECC
ECM
EIF
EMB
EMF
EMK
EMOBN
EPL
ESE
ESN
FA8
FAC
J5H
L-9
LGEZI
LOTEE
MVM
N4W
NADUK
NEJ
NPM
NXXTH
ODYON
OHT
P-O
PEA
PM3
PV9
QS-
R4F
RHI
SKT
TH9
TUD
UAO
UBY
UHB
USG
VOH
X7L
XOL
YJ6
YQI
YQJ
YV5
YXA
YYP
YYQ
ZCG
ZGI
ZHY
ZKB
ZKG
ZY4
~8M
~G0
ACMFV
AEIIB
PMFND
7QG
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7TG
7TK
7TM
7TO
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
KL.
M7N
MBDVC
P64
PKEHL
PQEST
PQUKI
Q9U
RC3
SOI
7X8
5PM
ID FETCH-LOGICAL-c593t-4639d46669d7b71a2ee1f9a2d0c9f28fa0c8a4beaabe6aec60ad6651c6dc6c283
IEDL.DBID M2M
ISICitedReferencesCount 452
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000457404000050&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0028-0836
1476-4687
IngestDate Tue Nov 04 01:55:42 EST 2025
Sun Nov 09 10:27:58 EST 2025
Sat Nov 29 14:41:48 EST 2025
Tue Nov 11 10:31:29 EST 2025
Sat Nov 29 11:29:24 EST 2025
Tue Jun 10 15:32:30 EDT 2025
Tue Nov 04 17:59:32 EST 2025
Thu Nov 13 15:52:10 EST 2025
Wed Feb 19 02:31:45 EST 2025
Tue Nov 18 22:25:31 EST 2025
Sat Nov 29 02:38:45 EST 2025
Fri Feb 21 02:37:45 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7741
Language English
License Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c593t-4639d46669d7b71a2ee1f9a2d0c9f28fa0c8a4beaabe6aec60ad6651c6dc6c283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Present address: Medical Genetics and Human Genomics, Department of Pediatrics, Northwell Health; 350 Community Dr.; Suite 2133A; Manhasset, NY 11030.
AUTHOR CONTRIBUTIONS
AUTHOR INFORMATION
Reprints and permissions information is available at www.nature.com/reprints. EIP reports advisory roles with AstraZeneca. VT is a founding investigator of Blue Rock Therapeutics. KSP reports stock ownership in Pfizer. LMD reports advisory roles for Sapience Therapeutics, Tocagen, BTG International, Roche, and Syndax. RJY reports research funding from Agios and advisory roles with Icon plc, NordicNeuroLab, and Puma Biotechnology. MFB reports advisory roles with Roche and research funding from Illumina. IKM reports research funding from General Electric, Amgen, and Lilly; advisory roles with Agios, Puma Biotechnology, and Debiopharm Group; and honoraria from Roche for a presentation. Correspondence and requests for materials should be addressed to bergerm1@mskcc.org and mellingi@mskcc.org.
AMM, RHS, and EIP contributed equally to this work.
AMM, RHS, EIP, LMD, RJY, MFB and IKM conceived and designed the study. AMM, RHS, EIP, RJY, MFB and IKM collected and assembled the data. AMM, RHS, EIP, MP, SB, ND, AS, SDS, LL, FM, XJ, CG, AV, MMS, VT, CWB, MR, RJY, MFB and IKM were responsible for provision of the study materials and the patients. AMM, RHS, EIP, YZ, AR, KP, RJY, MFB, IKM analyzed and interpreted the data. MP, CC, SAM, AS, FM processed the CSF and blood samples. AMM, RHS, EIP, W-YH, TAB, AV, LMD, KP, RJY, MFB, IKM provided administrative, material and technical support. AMM, RHS, EIP, DWT, CG, LMD, KP, RJY, MFB, IKM wrote the manuscript. All authors approved the manuscript.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC6457907
PMID 30675060
PQID 2178519857
PQPubID 40569
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6457907
proquest_miscellaneous_2179445529
proquest_journals_2178519857
gale_infotracmisc_A573274151
gale_infotracgeneralonefile_A573274151
gale_infotraccpiq_573274151
gale_infotracacademiconefile_A573274151
gale_incontextgauss_ISR_A573274151
pubmed_primary_30675060
crossref_citationtrail_10_1038_s41586_019_0882_3
crossref_primary_10_1038_s41586_019_0882_3
springer_journals_10_1038_s41586_019_0882_3
PublicationCentury 2000
PublicationDate 20190101
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 1
  year: 2019
  text: 20190101
  day: 1
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle International weekly journal of science
PublicationTitle Nature (London)
PublicationTitleAbbrev Nature
PublicationTitleAlternate Nature
PublicationYear 2019
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Hunter (CR19) 2006; 66
Bai (CR6) 2016; 48
Bettegowda (CR12) 2014; 6
Lee (CR10) 2017; 49
Suzuki (CR3) 2015; 47
Wang (CR9) 2016; 48
Zehir (CR24) 2017; 23
Pentsova (CR13) 2016; 34
Kim (CR7) 2015; 25
Brat (CR16) 2015; 372
Brennan (CR21) 2013; 155
Wen (CR25) 2017; 35
Wang (CR14) 2015; 112
Consortium (CR23) 2017; 7
Abecasis (CR26) 2012; 491
Aihara (CR5) 2017; 5
Thorvaldsdóttir, Robinson, Mesirov (CR27) 2013; 14
Alexandrov (CR20) 2013; 500
Tomita-Mitchell (CR18) 2000; 450
Johnson (CR4) 2014; 343
Merker (CR11) 2018; 36
Louis (CR1) 2016; 131
Kim (CR8) 2015; 28
Shen, Seshan (CR28) 2016; 44
(CR2) 2008; 455
Cheng (CR15) 2015; 17
Parsons (CR22) 2008; 321
Eckel-Passow (CR17) 2015; 372
C Hunter (882_CR19) 2006; 66
J Kim (882_CR8) 2015; 28
DJ Brat (882_CR16) 2015; 372
A Zehir (882_CR24) 2017; 23
JE Eckel-Passow (882_CR17) 2015; 372
DW Parsons (882_CR22) 2008; 321
R Shen (882_CR28) 2016; 44
Y Wang (882_CR14) 2015; 112
CW Brennan (882_CR21) 2013; 155
K Aihara (882_CR5) 2017; 5
H Bai (882_CR6) 2016; 48
BE Johnson (882_CR4) 2014; 343
J Wang (882_CR9) 2016; 48
DT Cheng (882_CR15) 2015; 17
JK Lee (882_CR10) 2017; 49
H Kim (882_CR7) 2015; 25
H Suzuki (882_CR3) 2015; 47
LB Alexandrov (882_CR20) 2013; 500
PY Wen (882_CR25) 2017; 35
DN Louis (882_CR1) 2016; 131
EI Pentsova (882_CR13) 2016; 34
JD Merker (882_CR11) 2018; 36
GR Abecasis (882_CR26) 2012; 491
C Bettegowda (882_CR12) 2014; 6
A Tomita-Mitchell (882_CR18) 2000; 450
APG Consortium (882_CR23) 2017; 7
H Thorvaldsdóttir (882_CR27) 2013; 14
Cancer Genome Atlas Research Network (882_CR2) 2008; 455
31304547 - Neurosurgery. 2019 Aug 1;85(2):E196-E197
31836074 - Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):1-4
References_xml – volume: 25
  start-page: 316
  year: 2015
  end-page: 327
  ident: CR7
  article-title: Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
  publication-title: Genome Res.
  doi: 10.1101/gr.180612.114
– volume: 28
  start-page: 318
  year: 2015
  end-page: 328
  ident: CR8
  article-title: Spatiotemporal evolution of the primary glioblastoma genome
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.07.013
– volume: 47
  start-page: 458
  year: 2015
  end-page: 468
  ident: CR3
  article-title: Mutational landscape and clonal architecture in grade II and III gliomas
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3273
– volume: 48
  start-page: 768
  year: 2016
  end-page: 776
  ident: CR9
  article-title: Clonal evolution of glioblastoma under therapy
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3590
– volume: 343
  start-page: 189
  year: 2014
  end-page: 193
  ident: CR4
  article-title: Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
  publication-title: Science
  doi: 10.1126/science.1239947
– volume: 36
  start-page: 1631
  year: 2018
  end-page: 1641
  ident: CR11
  article-title: Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.76.8671
– volume: 455
  start-page: 1061
  year: 2008
  end-page: 1068
  ident: CR2
  article-title: Comprehensive genomic characterization defines human glioblastoma genes and core pathways
  publication-title: Nature
  doi: 10.1038/nature07385
– volume: 44
  start-page: e131
  year: 2016
  ident: CR28
  article-title: FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkw520
– volume: 5
  start-page: 18
  year: 2017
  ident: CR5
  article-title: Genetic and epigenetic stability of oligodendrogliomas at recurrence
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-017-0422-z
– volume: 66
  start-page: 3987
  year: 2006
  end-page: 3991
  ident: CR19
  article-title: A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-0127
– volume: 321
  start-page: 1807
  year: 2008
  end-page: 1812
  ident: CR22
  article-title: An integrated genomic analysis of human glioblastoma multiforme
  publication-title: Science
  doi: 10.1126/science.1164382
– volume: 450
  start-page: 125
  year: 2000
  end-page: 138
  ident: CR18
  article-title: Mismatch repair deficient human cells: spontaneous and MNNG-induced mutational spectra in the HPRT gene
  publication-title: Mutat. Res.
  doi: 10.1016/S0027-5107(00)00020-8
– volume: 49
  start-page: 594
  year: 2017
  end-page: 599
  ident: CR10
  article-title: Spatiotemporal genomic architecture informs precision oncology in glioblastoma
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3806
– volume: 155
  start-page: 462
  year: 2013
  end-page: 477
  ident: CR21
  article-title: The somatic genomic landscape of glioblastoma
  publication-title: Cell
  doi: 10.1016/j.cell.2013.09.034
– volume: 23
  start-page: 703
  year: 2017
  end-page: 713
  ident: CR24
  article-title: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
  publication-title: Nat. Med.
  doi: 10.1038/nm.4333
– volume: 14
  start-page: 178
  year: 2013
  end-page: 192
  ident: CR27
  article-title: Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
  publication-title: Brief. Bioinform.
  doi: 10.1093/bib/bbs017
– volume: 17
  start-page: 251
  year: 2015
  end-page: 264
  ident: CR15
  article-title: Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
  publication-title: JMD
– volume: 491
  start-page: 56
  year: 2012
  end-page: 65
  ident: CR26
  article-title: An integrated map of genetic variation from 1,092 human genomes
  publication-title: Nature
  doi: 10.1038/nature11632
– volume: 34
  start-page: 2404
  year: 2016
  end-page: 2415
  ident: CR13
  article-title: Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2016.66.6487
– volume: 500
  start-page: 415
  year: 2013
  end-page: 421
  ident: CR20
  article-title: Signatures of mutational processes in human cancer
  publication-title: Nature
  doi: 10.1038/nature12477
– volume: 7
  start-page: 818
  year: 2017
  end-page: 831
  ident: CR23
  article-title: AACR Project GENIE: powering precision medicine through an international consortium
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-17-0151
– volume: 372
  start-page: 2481
  year: 2015
  end-page: 2498
  ident: CR16
  article-title: Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1402121
– volume: 372
  start-page: 2499
  year: 2015
  end-page: 2508
  ident: CR17
  article-title: Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1407279
– volume: 131
  start-page: 803
  year: 2016
  end-page: 820
  ident: CR1
  article-title: The 2016 World Health Organization classification of tumors of the central nervous system: a summary
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-016-1545-1
– volume: 48
  start-page: 59
  year: 2016
  end-page: 66
  ident: CR6
  article-title: Integrated genomic characterization of IDH1-mutant glioma malignant progression
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3457
– volume: 6
  start-page: 224ra24
  year: 2014
  ident: CR12
  article-title: Detection of circulating tumor DNA in early- and late-stage human malignancies
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3007094
– volume: 35
  start-page: 2439
  year: 2017
  end-page: 2449
  ident: CR25
  article-title: Response assessment in neuro-oncology clinical trials
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.72.7511
– volume: 112
  start-page: 9704
  year: 2015
  end-page: 9709
  ident: CR14
  article-title: Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1511694112
– volume: 48
  start-page: 59
  year: 2016
  ident: 882_CR6
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3457
– volume: 34
  start-page: 2404
  year: 2016
  ident: 882_CR13
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2016.66.6487
– volume: 372
  start-page: 2481
  year: 2015
  ident: 882_CR16
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1402121
– volume: 491
  start-page: 56
  year: 2012
  ident: 882_CR26
  publication-title: Nature
  doi: 10.1038/nature11632
– volume: 321
  start-page: 1807
  year: 2008
  ident: 882_CR22
  publication-title: Science
  doi: 10.1126/science.1164382
– volume: 7
  start-page: 818
  year: 2017
  ident: 882_CR23
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-17-0151
– volume: 49
  start-page: 594
  year: 2017
  ident: 882_CR10
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3806
– volume: 372
  start-page: 2499
  year: 2015
  ident: 882_CR17
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1407279
– volume: 25
  start-page: 316
  year: 2015
  ident: 882_CR7
  publication-title: Genome Res.
  doi: 10.1101/gr.180612.114
– volume: 36
  start-page: 1631
  year: 2018
  ident: 882_CR11
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.76.8671
– volume: 131
  start-page: 803
  year: 2016
  ident: 882_CR1
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-016-1545-1
– volume: 23
  start-page: 703
  year: 2017
  ident: 882_CR24
  publication-title: Nat. Med.
  doi: 10.1038/nm.4333
– volume: 6
  start-page: 224ra24
  year: 2014
  ident: 882_CR12
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3007094
– volume: 155
  start-page: 462
  year: 2013
  ident: 882_CR21
  publication-title: Cell
  doi: 10.1016/j.cell.2013.09.034
– volume: 343
  start-page: 189
  year: 2014
  ident: 882_CR4
  publication-title: Science
  doi: 10.1126/science.1239947
– volume: 450
  start-page: 125
  year: 2000
  ident: 882_CR18
  publication-title: Mutat. Res.
  doi: 10.1016/S0027-5107(00)00020-8
– volume: 14
  start-page: 178
  year: 2013
  ident: 882_CR27
  publication-title: Brief. Bioinform.
  doi: 10.1093/bib/bbs017
– volume: 5
  start-page: 18
  year: 2017
  ident: 882_CR5
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-017-0422-z
– volume: 500
  start-page: 415
  year: 2013
  ident: 882_CR20
  publication-title: Nature
  doi: 10.1038/nature12477
– volume: 28
  start-page: 318
  year: 2015
  ident: 882_CR8
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.07.013
– volume: 47
  start-page: 458
  year: 2015
  ident: 882_CR3
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3273
– volume: 48
  start-page: 768
  year: 2016
  ident: 882_CR9
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3590
– volume: 112
  start-page: 9704
  year: 2015
  ident: 882_CR14
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1511694112
– volume: 17
  start-page: 251
  year: 2015
  ident: 882_CR15
  publication-title: JMD
– volume: 455
  start-page: 1061
  year: 2008
  ident: 882_CR2
  publication-title: Nature
  doi: 10.1038/nature07385
– volume: 35
  start-page: 2439
  year: 2017
  ident: 882_CR25
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.72.7511
– volume: 66
  start-page: 3987
  year: 2006
  ident: 882_CR19
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-0127
– volume: 44
  start-page: e131
  year: 2016
  ident: 882_CR28
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkw520
– reference: 31304547 - Neurosurgery. 2019 Aug 1;85(2):E196-E197
– reference: 31836074 - Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):1-4
SSID ssj0005174
Score 2.69462
Snippet Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III...
Diffuse gliomas comprise the most common malignant brain tumors in adults and include glioblastomas (GBM) and World Health Organization (WHO) grade II and...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 654
SubjectTerms 631/1647/2217
631/67/1922
Adults
Analysis
Biopsy
Blood circulation
Brain
Brain cancer
Brain tumors
Cancer therapies
Cerebrospinal fluid
Chemotherapy
Chromosome deletion
Consortia
Deoxyribonucleic acid
Development and progression
Diagnosis
DNA
Evolution
Evolution, Molecular
Gene deletion
Genes, Neoplasm - genetics
Genome, Human - genetics
Genomes
Genomics
Genotypes
Genotyping
Glioblastoma - cerebrospinal fluid
Glioblastoma - genetics
Glioblastoma - pathology
Glioma
Glioma - cerebrospinal fluid
Glioma - genetics
Glioma - pathology
Gliomas
Growth factors
Humanities and Social Sciences
Humans
Isocitrate dehydrogenase
Letter
Liquid Biopsy
Methods
Morbidity
multidisciplinary
Mutation
Neoplasm Grading
Oncology
Patients
Science
Science (multidisciplinary)
Signal transduction
Signs and symptoms
Surgery
Telomerase
Tumorigenesis
Tumors
Title Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
URI https://link.springer.com/article/10.1038/s41586-019-0882-3
https://www.ncbi.nlm.nih.gov/pubmed/30675060
https://www.proquest.com/docview/2178519857
https://www.proquest.com/docview/2179445529
https://pubmed.ncbi.nlm.nih.gov/PMC6457907
Volume 565
WOSCitedRecordID wos000457404000050&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAQT
  databaseName: Nature
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: RNT
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.nature.com
  providerName: Nature Publishing
– providerCode: PRVPQU
  databaseName: Advanced Technologies & Aerospace Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: P5Z
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/hightechjournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Agricultural Science Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: M0K
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/agriculturejournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: M7P
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Earth, Atmospheric & Aquatic Science Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: PCBAR
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eaasdb
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Engineering Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: M7S
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: http://search.proquest.com
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Environmental Science Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: PATMY
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/environmentalscience
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: 7X7
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Materials Science Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: KB.
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/materialsscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: 7RV
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: BENPR
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: M2M
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: 8C1
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: M2O
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1476-4687
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0005174
  issn: 0028-0836
  databaseCode: M2P
  dateStart: 19880107
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1rb9Mw0GIbSHwBNl5hozII8VRYnn58Qtu0CTS1VB1DFV8sx7FLpC5pm3a_H9tx26WCfeHLSdFd4jj3tH25A-BNJhAOJVU-UYk5ZsS5n6E49JVUCpE8wVkkbLMJ3OuR4ZD23YZb7dIqlzbRGuq8EmaP_DCybeQpSfGXydQ3XaPM6aprobEFdnSgTIxidqPuOsVjowrz8lQzJoe1dlzErKWpb4PMuOWXNq3zDfe0mTq5cX5q3dLZw_-d0CPwwAWk8KiRoF1wR5Z74J5NDBX1Hth1yl_D965C9YfHYKA9nDB77HC-uNIPgPLaSTAsSjgaF9UVh64DEBwX00WRw6yoJrVelsNKQSFneiluOpaYodVY45-Ay7PTHydffdecwRcpjed-okObPNGLH5rjDIc8kjJUlEd5IKiKiOKBIDzJJOeZRFwKFPAcoTQUKBdI6KDmKdguq1I-B5Bqq6nDDsFFRBOV8CxCWKJEhRiLUGDkgWDJGiZc5XLTQGPM7Al6TFjDTaa5yQw3WeyBj6tbJk3ZjtuIXxt-M1MOozT5NiO-qGv27WLAjlIcmwI_aeiBd45IVXpw_bLN7wt6CqaCVotyv0UpJsWU3cC-bWFHDe_-9piDFqFWe9FGL8WKObNTs7VMeeDVCm3uNKl0pawWloYmSZpG1APPGmFefSK7fgxQ4AHcEvMVgSlG3saUxW9blBwlKaaBHvfTUiHWr_XPL__i9knsg_uR1VCz43UAtuezhXwJ7orreVHPOmALD34aOMQWEg3JSdgBO8envf5AX50ff9awG5x3rF2w8LuFfQNxAy807Ke__gA-JWV_
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKAcEFaHmFFjCIN4qaOI4dHxCqgKqrlqUqRerNOI69RNomu5vdIv4UvxHbSXabFfTWA-cZPzMP2zP5BoBnqSQ0VEz7icY2zEgzPyVR6GulNUkyTFMkXbEJ2u8nx8fsYAX8bv-FsWmVrU10hjorpX0j30KujDxLYvp-NPZt1SgbXW1LaNRisad-_TRXtupd76P5vs8R2vl09GHXb6oK-DJm0dTHxidn2JzaWUZTGgqkVKiZQFkgmUaJFoFMBE6VEKkiQkkSiIyQOJQkk0Qab2z6vQQuY3sTsqmC6MsipWQJ9bmNokbJVmUcZWLv7sx3h9qo4weXvcEZd7icqrkUr3VucOfm_7aBt8CN5sANt2sNWQMrqlgHV13iq6zWwVpj3Cr4qkHgfn0bHBoPLm0MAU5nJ6YDqE4bDYV5AQfDvDwRsKlwBIf5eJZnMM3LUZWbfkoNpZqodGIrstih9dDQ74BvF7LKu2C1KAt1H0BmvII5VkkhEcMaixQRqgjWIaUylJR4IGhFgcsGmd0WCBlylyEQJbyWHm6kh1vp4ZEH3sybjGpYkvOYn1r54hbuo7D5RAMxqyre-3rIt2MaWQCjOPTAy4ZJl2ZwM9n69wyzBIsQ1uHc6HDKUT7mZ6gvOtRB_e3-1s1mh9GYNdklt2LMG7Na8YUMe-DJnGxb2lTBQpUzx8MwjmPEPHCvVp75Frn7cUACD9COWs0ZLNh6l1LkPxzoOsExZYEZ922rgItp_XPnH5y_iMfg2u7R532-3-vvbYDryFkH-7q3CVank5l6CK7I02leTR45OwPB94vWyz_LILm-
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8hAXoOUVWsAg3ihqnnZ8QKiirFgVraoWpIqLcRx7ibRNdje7Rfw1fh22k-w2K-itB84zsWNnHh7P5BuAZ6nAxJdUuYmKTJqRZG6KQ99VUimcZBFJA2GbTZDBIDk-pgdr8Lv9F8aUVbY20RrqrBTmjnwnsG3kaaIDeNWURRzs9d6PJ67pIGUyrW07jVpE9uWvnzp8q9719_S3fh4EvY9fPnxymw4DrohpOHMj7Z-zSJ_gaUZS4vNASl9RHmSeoCpIFPdEwqNUcp5KzKXAHs8wjn2BM4GF9sx63EtwmegY05QTHsTfluUlKwjQbUY1THYq7TQTE8dT1x5ww45PXPUMZ1zjatnmSu7WusTezf95M2_BjeYgjnZrzdmANVlswlVbECuqTdhojF6FXjXI3K9vw6H27MLkFtBsfqIHQPK00VyUF2g4yssTjprOR2iUT-Z5htK8HFe5HqdUSMipTKemU4uZWo00_Q58vZBV3oX1oizkfUBUewt93BJcBDRSEU8DTCSOlE-I8AXBDnitWDDRILabxiEjZisHwoTVksS0JDEjSSx04M3ikXENV3Ie81Mja8zAgBRGBoZ8XlWsf3TIdmMSGmCj2HfgZcOkSj25ftn6tw29BIMc1uHc6nCKcT5hZ6gvOtRh_e3-Nsx2h1GbO9EltyLNGnNbsaU8O_BkQTZPmhLCQpZzy0OjKI4D6sC9WpEWW2TjZg97DpCOii0YDAh7l1LkPywYO45iQj0979tWGZev9c-df3D-Ih7DNa2O7HN_sL8F1wNrKMyl3zasz6Zz-RCuiNNZXk0fWZOD4PtFq-Uf-E7CrQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tracking+tumour+evolution+in+glioma+through+liquid+biopsies+of+cerebrospinal+fluid&rft.jtitle=Nature+%28London%29&rft.au=Miller%2C+Alexandra+M.&rft.au=Shah%2C+Ronak+H.&rft.au=Pentsova%2C+Elena+I.&rft.au=Pourmaleki%2C+Maryam&rft.date=2019-01-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0028-0836&rft.eissn=1476-4687&rft.volume=565&rft.issue=7741&rft.spage=654&rft.epage=658&rft_id=info:doi/10.1038%2Fs41586-019-0882-3&rft.externalDocID=10_1038_s41586_019_0882_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-0836&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-0836&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-0836&client=summon